Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis
Science Advances · 08.11.2024 · 10 (45)
DOI: 10.1126/sciadv.adr3997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 08.11.2024. Verfasst von Sadra Bakhshandeh und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany. Hauptthemen laut MEDLINE: LIM-Homeodomain Proteins, Muscle Proteins, Signal Transduction, Transcription Factors. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Solid cancers frequently relapse with distant metastasis, despite local and systemic treatment. Cellular dormancy has been identified as an important mechanism underlying drug resistance enabling late relapse. Therefore, relapse from invisible, minimal residual cancer of seemingly disease-free patients call for in vitro models of dormant cells suited for drug discovery. Here, we explore dormancy-inducing 3D engineered matrices, which generate mechanical confinement and induce growth arrest and survival against chemotherapy in cancer cells. We characterized the dormant phenotype of solitary cells by P-ERK low :P-p38 high dormancy signaling ratio, along with Ki67 − expression. As underlying mechanism, we identified stiffness-dependent nuclear localization of the four-and-a-half LIM domain 2 (FHL2) protein, leading to p53-independent high p21 Cip1/Waf1 nuclear expression, validated in murine and human tissue. Suggestive of a resistance-causing role, cells in the dormancy-inducing matrix became sensitive against chemotherapy upon FHL2 down-regulation. Thus, our biomaterial-based approach will enable systematic screens for previously unidentified compounds suited to eradicate potentially relapsing dormant cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
- Group of Bioengineering in Regeneration and Cancer, Biogipuzkoa Health Research Institute, San Sebastian, Spain.
- Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain.
- Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.
- Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
- Group of Breast Cancer, Biogipuzkoa Health Research Institute, San Sebastian, Spain.
ORCID-Profile: Unai Heras, Hubert M Taïeb, Adithi R Varadarajan, Susanna M Lissek, Sarah M Hücker, Daniela S Garske, Sarah A E Young, Andrea Abaurrea, Maria M Caffarel, Ana Riestra, Paloma Bragado, Jörg Contzen, Manfred Gossen, Jens Warfsmann, Christoph A Klein, Amaia Cipitria
Zitieren
APA
Bakhshandeh, S., Heras, U., Taïeb, H. M., Varadarajan, A. R., Lissek, S. M., Hücker, S. M., Lu, X., Garske, D. S., Young, S. A. E., Abaurrea, A., Caffarel, M. M., Riestra, A., Bragado, P., Contzen, J., Gossen, M., Kirsch, S., Warfsmann, J., Honarnejad, K., Klein, C. A., & Cipitria, A. (2024). Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis. Science Advances, 10(45). https://doi.org/10.1126/sciadv.adr3997
Vancouver
Bakhshandeh S, Heras U, Taïeb HM, Varadarajan AR, Lissek SM, Hücker SM, et al. Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis. Science Advances. 2024;10(45). doi:10.1126/sciadv.adr3997
BibTeX
@article{Bakhshandeh2024,
author = {Bakhshandeh, Sadra and Heras, Unai and Taïeb, Hubert M and Varadarajan, Adithi R and Lissek, Susanna M and Hücker, Sarah M and Lu, Xin and Garske, Daniela S and Young, Sarah A E and Abaurrea, Andrea and Caffarel, Maria M and Riestra, Ana and Bragado, Paloma and Contzen, Jörg and Gossen, Manfred and Kirsch, Stefan and Warfsmann, Jens and Honarnejad, Kamran and Klein, Christoph A and Cipitria, Amaia},
title = {Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {45},
doi = {10.1126/sciadv.adr3997}
}
EUVIMED